115 related articles for article (PubMed ID: 25614317)
21. Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer.
Aicher TD; Van Huis CA; Hurd AR; Skalitzky DJ; Taylor CB; Beleh OM; Glick G; Toogood PL; Yang B; Zheng T; Huo C; Gao J; Qiao C; Tian X; Zhang J; Demock K; Hao LY; Lesch CA; Morgan RW; Moisan J; Wang Y; Scatina J; Paulos CM; Zou W; Carter LL; Hu X
J Med Chem; 2021 Sep; 64(18):13410-13428. PubMed ID: 34499493
[TBL] [Abstract][Full Text] [Related]
22. Role of Melatonin in the Regulation of Differentiation of T Cells Producing Interleukin-17 (Th17).
Kuklina EM; Glebezdina NS; Nekrasova IV
Bull Exp Biol Med; 2016 Mar; 160(5):656-8. PubMed ID: 27021094
[TBL] [Abstract][Full Text] [Related]
23. A marine carotenoid, fucoxanthin, induces regulatory T cells and inhibits Th17 cell differentiation in vitro.
Kawashima T
Biosci Biotechnol Biochem; 2011; 75(10):2066-9. PubMed ID: 21979096
[TBL] [Abstract][Full Text] [Related]
24. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.
Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM
Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-155 may be involved in the pathogenesis of atopic dermatitis by modulating the differentiation and function of T helper type 17 (Th17) cells.
Ma L; Xue HB; Wang F; Shu CM; Zhang JH
Clin Exp Immunol; 2015 Jul; 181(1):142-9. PubMed ID: 25761610
[TBL] [Abstract][Full Text] [Related]
26. Novel benzenediamine derivative FC99 ameliorates zymosan-induced arthritis by inhibiting RORγt expression and Th17 cell differentiation.
Ji J; Dou H; Li X; Song Y; Li X; Li E; Tan R; Hou Y
Acta Biochim Biophys Sin (Shanghai); 2014 Oct; 46(10):829-36. PubMed ID: 25187413
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of RORγt activity and Th17 differentiation by a set of novel compounds.
Ding Q; Zhao M; Bai C; Yu B; Huang Z
BMC Immunol; 2015 May; 16():32. PubMed ID: 26021566
[TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
[TBL] [Abstract][Full Text] [Related]
29. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol).
Wang Y; Kumar N; Crumbley C; Griffin PR; Burris TP
Biochim Biophys Acta; 2010 Aug; 1801(8):917-23. PubMed ID: 20211758
[TBL] [Abstract][Full Text] [Related]
30. Yin-Yang Regulation of RORγt Protein Complex in Th17 Differentiation.
Gao W; Wu Y; Tian Y; Ni B
Int Rev Immunol; 2015; 34(4):295-304. PubMed ID: 25340306
[TBL] [Abstract][Full Text] [Related]
31. Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing RORγt Activity and Suppressing Th17 Cell Differentiation.
Ding Q; Zhao M; Yu B; Bai C; Huang Z
PLoS One; 2015; 10(9):e0137711. PubMed ID: 26368822
[TBL] [Abstract][Full Text] [Related]
32. IMMUNOLOGY. An RNA twist to T(H)17 cells.
Atianand MK; Fitzgerald KA
Science; 2016 Mar; 351(6277):1032. PubMed ID: 26941307
[No Abstract] [Full Text] [Related]
33. Discovery of biaryl carboxylamides as potent RORγ inverse agonists.
Chao J; Enyedy I; Van Vloten K; Marcotte D; Guertin K; Hutchings R; Powell N; Jones H; Bohnert T; Peng CC; Silvian L; Hong VS; Little K; Banerjee D; Peng L; Taveras A; Viney JL; Fontenot J
Bioorg Med Chem Lett; 2015 Aug; 25(15):2991-7. PubMed ID: 26048806
[TBL] [Abstract][Full Text] [Related]
34. Structure-Based Design and Synthesis of Fluorene Derivatives as Novel RORγt Inverse Agonists.
Gabr MT; Abdel-Raziq MS
Chem Biodivers; 2018 Sep; 15(9):e1800244. PubMed ID: 29935095
[TBL] [Abstract][Full Text] [Related]
35. Th17 cell development: from the cradle to the grave.
Zúñiga LA; Jain R; Haines C; Cua DJ
Immunol Rev; 2013 Mar; 252(1):78-88. PubMed ID: 23405896
[TBL] [Abstract][Full Text] [Related]
36. IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis.
Yamashita T; Iwakura T; Matsui K; Kawaguchi H; Obana M; Hayama A; Maeda M; Izumi Y; Komuro I; Ohsugi Y; Fujimoto M; Naka T; Kishimoto T; Nakayama H; Fujio Y
Cardiovasc Res; 2011 Sep; 91(4):640-8. PubMed ID: 21622681
[TBL] [Abstract][Full Text] [Related]
37. Signaling Pathways and Epigenetic Regulations in the Control of RORγt Expression in T Helper 17 Cells.
Tian Y; Wu Y; Ni B
Int Rev Immunol; 2015; 34(4):305-17. PubMed ID: 24801756
[TBL] [Abstract][Full Text] [Related]
38. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel quinazolinedione derivatives as RORγt inverse agonist.
Fukase Y; Sato A; Tomata Y; Ochida A; Kono M; Yonemori K; Koga K; Okui T; Yamasaki M; Fujitani Y; Nakagawa H; Koyama R; Nakayama M; Skene R; Sang BC; Hoffman I; Shirai J; Yamamoto S
Bioorg Med Chem; 2018 Feb; 26(3):721-736. PubMed ID: 29342416
[TBL] [Abstract][Full Text] [Related]
40. Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma.
Liljevald M; Rehnberg M; Söderberg M; Ramnegård M; Börjesson J; Luciani D; Krutrök N; Brändén L; Johansson C; Xu X; Bjursell M; Sjögren AK; Hornberg J; Andersson U; Keeling D; Jirholt J
Autoimmun Rev; 2016 Nov; 15(11):1062-1070. PubMed ID: 27491564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
